National Foundation for Cancer Research

Recent papers from National Foundation for Cancer Research

1. Machine Learning Identifies Community-Level Factors Associated with Lung Cancer IncidenceCancer Epidemiology Biomarkers & Prevention · 2026
2. A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate CancerCancer Research Communications · 2026
3. Safety and efficacy of intratumoral MEDI1191, an IL-12 mRNA lipid nanoparticle, plus intravenous durvalumab in patients with advanced solid tumors: a first-in-human studyClinical Cancer Research · 2026
4. A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial – Prognostic role of tumor PD-L1 expressionOral Oncology · 2026
5. Enhancing Clinical Skills Among Non‐Intensivists Caring for Critically Ill Children With Cancer: A Transnational Educational WorkshopPediatric Blood & Cancer · 2026
6. The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinomaExpert Review of Anticancer Therapy · 2026
7. Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cellsCell Reports · 2026
8. Spotting it soonerDental Nursing · 2026
9. GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to ImmunotherapyMolecular Cancer Therapeutics · 2026
10. Co-Development and Usability Testing of S-IMCICA: A User-Centered Web-Based E-Learning Curriculum in Early Childhood Cancer Detection for Primary Care Providers in Colombia.2026
11. HPV Self-Sampling for Cervical Cancer Screening in Morocco: A Cross-Sectional StudyAsian Pacific Journal of Cancer Prevention · 2026
12. Abstract 1228: Disparities in post-survivorship psychiatric diagnoses among adult cancer patients in a multi-center academic health system.Cancer Research · 2026
13. Abstract 5333: Profiling membrane antigen expression of select antibody-drug conjugate (ADC) targets in EGFR -altered non-small cell lung cancer treated with osimertinib.Cancer Research · 2026
14. Cancer Knowledge in Caregivers of Children With Cancer: Associations With Social Determinants of HealthPediatric Blood & Cancer · 2026
15. Assessing the Accuracy of Thyroid Nodule Risk Stratification Tools in Hispanic and Non-Hispanic PatientsJournal of the Endocrine Society · 2026
16. Characterizing Treatment Delays in Patients With HPV ‐Negative Oropharyngeal CancerCancer Medicine · 2026
17. Zanidatamab, a Dual HER2-Targeted Bispecific Antibody, in Patients With Unresectable Locally Advanced or Metastatic HER2-Positive Salivary Gland Cancer: A Combined Analysis of Early-Phase StudiesClinical Cancer Research · 2026
18. VIGICANCER: Understanding Real-World Childhood Cancer Clinical Outcomes in Colombia to Inform Cancer Control PolicyJCO Global Oncology · 2026
19. FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and ApalutamideEuropean Urology · 2026
20. The clinical utility of molecular residual disease testing in early-stage breast cancerExpert Review of Anticancer Therapy · 2026